Skip Navigation

About Kyle

Kyle practises corporate and securities law, including public and private company financings, mergers and acquisitions, and corporate reorganizations. He also advises clients in connection with securities law compliance, disclosure obligations, stock exchange matters, corporate governance and general corporate law. Kyle represents clients in a broad range of industries including life sciences, technology and mining.

Select Experience

Recent representative transactions include assisting:

M&A and Reorganizations

  • NervGen in connection with its C$23-million public offering of units

  • enGene in connection with its US$138-million de-SPAC merger with Forbion European Acquisition

  • Neovasc in connection with its acquisition by Shockwave for approximately US$100-million

  • NioCorp Developments Ltd. on its business combination with GX Acquisition Corp. II, a US special purpose acquisition corporation (SPAC), and concurrent financings valued at up to US$71.9-million

  • Trilogy International Partners in connection with the sale of its subsidiary, Two Degrees, for NZ$1.315-billion

  • Trillium Therapeutics Inc. in connection with its acquisition by Pfizer for US$2.22-billion

  • Absolute Software Corporation in connection with its US$340-million acquisition of NetMotion Software, Inc.

  • CRH Medical Corporation in connection with its acquisition by Well Health Technologies Corp. in a deal valued at US$372.9-million

  • Novoheart Holdings Inc. in a going private transaction valued at approximately C$100-million

  • Atico Mining Corporation in connection with its acquisition of Toachi Mining Inc.

  • Washington Companies in connection with its C$1.5-billion acquisition of Dominion Diamond Corporation

  • Trilogy International Partners on a US$875-million business combination with Alignvest Acquisition Corporation, a special purpose acquisition corporation (SPAC)

  • Neovasc in connection with the sale of its tissue business and concurrent private placement to Boston Scientific for US$75-million

  • Reservoir Minerals Inc. on its private placement, credit agreement and plan of arrangement with Nevsun Resources Ltd. for a total of US$575-million

  • Capstone Mining in connection with its acquisition of the Pinto Valley Mine from BHP Billiton for US$650-million

  • Lithium One Inc. in connection with its acquisition by Galaxy Resources for C$112-million in exchangeable shares

Corporate Finance

  • The underwriters in separate public offerings of CubicFarm Systems Corp. for gross proceeds of C$20-million, C$25.3-million, C$16.2-million and C$2.8-million

  • The underwriters in connection with a US$20-million public offering of units by Medicenna Therapeutics

  • NervGen Pharma in connection with its US$15.23-million private placement of units

  • ESSA Pharma Inc. in connection with its US$130-million underwritten public offering of common shares

  • Kadestone Capital Corp. on its formation and initial public offering

  • The underwriters in a C$23-million bought deal public offering of units of Rubicon Organics Inc.

  • Neovasc in connection with its US$72-million MJDS registered direct offering of common shares

  • Svante Technologies Inc. in connection with its US$16-million Series C preferred share financing, US$100-million Series D preferred share financing and US$318-million Series E preferred share financing

  • ESSA Pharma in connection with its US$26-million prospectus offering and concurrent private placement of common shares and pre-funded warrants

  • Neovasc in connection with its US$37.5-million underwritten offering of Series A and Series B units (comprised of a combination of common shares or Series D pre-funded warrants, Series C units and Series A, B, C and F warrants to purchase common shares) and concurrent US$27.8-million private placement of notes and Series E warrants to purchase common shares

  • The underwriters of B2Gold Corp. on its at-the-market offering of up to US$100-million

  • The underwriters on a private placement of flow-through common shares of Sabina Gold & Silver Corp. for gross proceeds of approximately C$34.5-million

  • Esperanza Resources Corp. on a private placement of special warrants for gross proceeds of approximately C$34-million

  • NovaGold Resources Inc. on a public offering of common shares for gross proceeds of approximately US$332.5-million
Awards & Recognition

Kyle is recognized as a leading lawyer in the following publications:

  • Lexpert Special Edition: Finance and M&A 2024

  • The Canadian Legal Lexpert Directory 2024 (Leading Lawyers to Watch – Corporate Finance & Securities)

Professional Activities

Kyle is a member of The Law Society of British Columbia and the Canadian Bar Association.

Education

Admitted to the British Columbia Bar – 2011
JD, University of Victoria – 2010
BBA (Hon.), Simon Fraser University – 2007

More insights

Save Profile

Select sections to customize your PDF

Cancel